Dr. Magrath is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
7 S Alliance Dr
Goose Creek, SC 29445Phone+1 843-792-2020- Is this information wrong?
Education & Training
- Medical University of South CarolinaResidency, Ophthalmology, 2011 - 2014
- Medical University of South Carolina College of MedicineInternship, Transitional Year, 2010 - 2011
- Medical University of South CarolinaClass of 2010
Certifications & Licensure
- SC State Medical License 2011 - 2025
- PA State Medical License 2014 - 2016
- American Board of Ophthalmology Ophthalmology
Awards, Honors, & Recognition
- Fellow (FACS) American College of Surgeons
Clinical Trials
- Study to Evaluate the Safety and Efficacy of Topical Minocycline Gel in Patients With Papulopustular Rosacea Start of enrollment: 2017 Oct 30
Publications & Presentations
PubMed
- Response of Bacillary Layer Detachment after Chemotherapy for Choroidal Lymphoma.Joseph Luvisi, Susannah Brown, George N Magrath> ;Ophthalmology. Retina. 2022 Dec 1
- 1 citationsInherited Retinal Dystrophy in Southeastern United States: Characterization of South Carolina Patients and Comparative Literature Review.Joseph Griffith 3rd, Kareem Sioufi, Laurie Wilbanks, George N Magrath, Emil A T Say, Michael J Lyons, Meg Wilkes, Gurpur Shashidhar Pai, Mae Millicent Winfrey Peterseim> ;Genes. 2022 Aug 20
- 154 citationsGlobal Retinoblastoma Presentation and Analysis by National Income LevelIdo Didi Fabian, Elhassan Abdallah, Shehu U. Abdullahi, Rula A. Abdulqader, Sahadatou Adamou Boubacar, Dupe S Ademola-Popoola, AO Adio, Armin R. Afshar, Priyanka Aggar...> ;JAMA Oncology. 2020 May 1
- Join now to see all
Press Mentions
- How AI Can Be Used to Help People SeeDecember 17th, 2022
- Ocuphire Pharma Announces Presentation on APX3330 at the Annual Angiogenesis, Exudation, and Degeneration 2024 ConferenceFebruary 6th, 2024
- Ocuphire Pharma Receives FDA Agreement for Phase 3 Trial of Phentolamine Solution for the Treatment of Decreased Visual Acuity Under Dim Light ConditionsJanuary 6th, 2024
Professional Memberships
- Member
Hospital Affiliations
- MUSC Health University Medical CenterCharleston, South Carolina
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: